State of New Jersey Common Pension Fund D - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,009,000
-25.0%
23,336
+34.5%
0.01%0.0%
Q4 2021$2,679,000
-25.3%
17,346
-32.6%
0.01%
-27.3%
Q3 2021$3,585,000
+34.7%
25,729
+26.8%
0.01%
+22.2%
Q2 2021$2,662,000
+53.3%
20,291
+78.0%
0.01%
+50.0%
Q1 2021$1,737,000
-24.1%
11,397
-50.5%
0.01%
-25.0%
Q4 2020$2,288,000
+10.1%
23,002
+5.5%
0.01%0.0%
Q3 2020$2,079,000
-2.7%
21,813
+14.2%
0.01%
-11.1%
Q2 2020$2,136,000
+44.7%
19,099
-5.9%
0.01%
+28.6%
Q1 2020$1,476,000
-30.3%
20,3000.0%0.01%
-12.5%
Q4 2019$2,117,000
+4.8%
20,3000.0%0.01%0.0%
Q3 2019$2,021,000
-92.3%
20,300
-91.2%
0.01%
-91.8%
Q2 2019$26,255,000
-0.5%
230,000
+9.5%
0.10%
-1.0%
Q1 2019$26,399,000
+76.9%
210,000
+90.9%
0.10%
+54.7%
Q4 2018$14,927,000
-22.3%
110,000
+57.1%
0.06%
-9.9%
Q3 2018$19,214,000
-7.3%
70,000
-30.0%
0.07%
-9.0%
Q2 2018$20,717,000
-10.4%
100,000
-28.6%
0.08%
-12.4%
Q1 2018$23,122,000
+20.6%
140,0000.0%0.09%
+21.9%
Q4 2017$19,170,000
+17.3%
140,000
+16.7%
0.07%
+12.3%
Q3 2017$16,338,000
-10.3%
120,000
-20.0%
0.06%
-13.3%
Q2 2017$18,210,000
-21.8%
150,000
-31.8%
0.08%
-22.7%
Q1 2017$23,285,000
-11.9%
220,000
-15.4%
0.10%
-14.2%
Q4 2016$26,419,000
-13.7%
260,000
-13.3%
0.11%
-14.4%
Q3 2016$30,618,000
+71.1%
300,000
+100.0%
0.13%
+63.0%
Q2 2016$17,891,000150,0000.08%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders